Admission Date:  [**2107-2-17**]              Discharge Date:   [**2107-2-25**]  Date of Birth:  [**2028-6-30**]             Sex:   M  Service: SURGERY  Allergies: Patient recorded as having No Known Allergies to Drugs  Attending:[**First Name3 (LF) 695**] Chief Complaint: UTI  Major Surgical or Invasive Procedure: none   History of Present Illness: 78M POD20/13 from left lat segementectomy followed by exploratory laparotomy and washout with subsequent bile leakage in mediastinum s/p drainage.
Son in area, daughter lives in CA>   Family History: Noncontributory  Physical Exam: Vital signs 96.5 105 137/80 16 99RA General: A+O x 3, NAD, notably listless and with malaise Card: RRR, no M/R/G Lungs: CTA bilaterally, no coughs or wheezes on exam with deep inspiration Abd: Soft, non-tender, non distended, no masses, open incision with fibrinopurulent superficial exudate, drain sites mildly erythematous but otherwise clean, dry, intact with bile-tinged sero-sanguinous output Extr: no peripheral edema noted  LABS/Studies: just arrived, still pending   Pertinent Results: [**2107-2-22**] 05:40AM BLOOD WBC-5.9 RBC-3.64* Hgb-10.5* Hct-31.8* MCV-87 MCH-28.9 MCHC-33.2 RDW-16.1* Plt Ct-363 [**2107-2-19**] 05:37AM BLOOD PT-13.7* PTT-24.5 INR(PT)-1.2* [**2107-2-25**] 05:45AM BLOOD Glucose-81 UreaN-21* Creat-0.9 Na-141 K-5.1 Cl-104 HCO3-31 AnGap-11 [**2107-2-21**] 06:13AM BLOOD ALT-12 AST-15 AlkPhos-40 TotBili-0.2 [**2107-2-23**] 05:48AM BLOOD Calcium-8.2* Phos-3.6 Mg-2.4  [**2107-2-17**] 4:43 pm URINE      Source: CVS.
**FINAL REPORT [**2107-2-24**]**     URINE CULTURE (Final [**2107-2-24**]):       ESCHERICHIA COLI.
CEFPODOXIME Susceptibility testing requested by  [**First Name4 (NamePattern1) **] [**Last Name (NamePattern1) **] [**Numeric Identifier 108415**]          [**2107-2-21**] AT 1800.
Cefpodoxime = INTERMEDIATE, sensitivity testing performed by [**First Name8 (NamePattern2) 3077**]          [**Last Name (NamePattern1) 3060**].
This is a concentrated smear made by cytospin method, please refer to       hematology for a quantitative white blood cell count..     FLUID CULTURE (Final [**2107-2-24**]):       ESCHERICHIA COLI.
CEFPODOXIME = SENSITIVE BY [**First Name8 (NamePattern2) **] [**Last Name (NamePattern1) **].
SENSITIVITIES: MIC expressed in MCG/ML  _________________________________________________________                              ESCHERICHIA COLI                              | AMPICILLIN------------   <=2 S AMPICILLIN/SULBACTAM--   <=2 S CEFAZOLIN-------------   <=4 S CEFEPIME--------------   <=1 S CEFTAZIDIME-----------   <=1 S CEFTRIAXONE-----------   <=1 S CIPROFLOXACIN---------<=0.25 S GENTAMICIN------------   <=1 S MEROPENEM-------------<=0.25 S PIPERACILLIN/TAZO-----   <=4 S TOBRAMYCIN------------   <=1 S TRIMETHOPRIM/SULFA----   <=1 S     ANAEROBIC CULTURE (Final [**2107-2-23**]):    NO ANAEROBES ISOLATED.
Brief Hospital Course: Given the patient's recent slight increase in drain output, recent discharge with drains for fluid collection, and the above symptoms, a CT scan was done to evaluate for fluid collection.
CT demonstrated smaller abdominal collections and left lower lung consolidation.
Blood cultures remained negative.
Urine cultured out for multi-drug resistant E. coli.
UA and culture were done.
Urine culture was pending at time of discharge.
The perihepatic drain output averaged 20-58cc/day.
Medications on Admission: FOSAMAX - 70MG Tablet - ONE BY MOUTH Q WEEK LEVOTHYROXINE [LEVOXYL] - 100 mcg Tablet - 1 Tablet(s) by mouth once a day VITAMIN D - [**Numeric Identifier 1871**] UNIT Capsule - ONE BY MOUTH Q WEEK  Medications - OTC ACETAMINOPHEN -  (Prescribed by Other Provider) - 325 mg Tablet - [**12-11**] Tablet(s) by mouth Q6hr as needed for pain CALCIUM CARBONATE-VIT D3-MIN [CALTRATE PLUS] -     Tablet - 1 Tablet(s) by mouth up to tid CYANOCOBALAMIN [VITAMIN B-12] -  (OTC) - 1,000 mcg Tablet - 2 Tablet(s) by mouth once a day FERROUS SULFATE -  (Prescribed by Other Provider) - 325 mg (65 mg Iron) Tablet - 1 Tablet(s) by mouth once a day Do not take in combination with thyroid pill LOPERAMIDE [IMODIUM A-D] -  (Prescribed by Other Provider) - 2 mg Tablet - 1 Tablet(s) by mouth q2h as needed for diarrhea --------------- --------------- --------------- ---------------   Discharge Medications: 1.
Ergocalciferol (Vitamin D2) 50,000 unit Capsule Sig: One (1) Capsule PO 1X/WEEK (SA).
Calcium 600 with Vitamin D3 600 mg(1,500mg) -400 unit Capsule Sig: One (1) Capsule PO twice a day.
Disp:*120 Tablet(s)* Refills:*2*   Discharge Disposition: Home With Service  Facility: [**Hospital 119**] Homecare  Discharge Diagnosis: Multidrug resistant E.coli UTI Malnutrition, moderate perihepatic collections   Discharge Condition: Mental Status: Clear and coherent Level of Consciousness: Alert and interactive Activity Status: Ambulatory - Independent   Discharge Instructions: Please call Dr.[**Name (NI) 1369**] office [**Telephone/Fax (1) 673**] if you experience any of the warning signs listed below Visiting Nurse Services will be arranged to do the abdominal wound dressing Continue to empty and record Drain outputs  Followup Instructions: [**First Name4 (NamePattern1) 698**] [**Last Name (NamePattern1) 699**] RN coordinator for Dr. [**Last Name (STitle) **] [**Telephone/Fax (1) 17195**]  Provider: [**First Name11 (Name Pattern1) **] [**Last Name (NamePattern4) 707**], MD, PHD[**MD Number(3) 708**]:[**Telephone/Fax (1) 673**] Date/Time:[**2107-3-2**] 1:00 Provider: [**First Name11 (Name Pattern1) **] [**Last Name (NamePattern1) 593**], MD Phone:[**Telephone/Fax (1) 22**] Date/Time:[**2107-3-14**] 1:30 Provider: [**Last Name (NamePattern4) **].
[**Last Name (STitle) 3150**] Phone:[**Telephone/Fax (1) 22**] Date/Time:[**2107-3-14**] 1:30                                [**First Name11 (Name Pattern1) **] [**Last Name (NamePattern4) 707**] MD, [**MD Number(3) 709**]  Completed by:[**2107-2-25**
